AIA Group Ltd Purchases Shares of 819 Stryker Co. (NYSE:SYK)

AIA Group Ltd bought a new position in Stryker Co. (NYSE:SYK - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 819 shares of the medical technology company's stock, valued at approximately $295,000.

Several other large investors have also bought and sold shares of SYK. Kohmann Bosshard Financial Services LLC purchased a new position in Stryker during the 4th quarter worth approximately $25,000. Dunhill Financial LLC raised its position in Stryker by 94.9% during the third quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company's stock valued at $27,000 after buying an additional 37 shares during the period. Rakuten Securities Inc. boosted its position in Stryker by 618.2% during the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after acquiring an additional 68 shares during the period. Centricity Wealth Management LLC purchased a new position in Stryker during the 4th quarter valued at about $30,000. Finally, BankPlus Trust Department acquired a new position in shares of Stryker in the 4th quarter valued at about $33,000. Institutional investors own 77.09% of the company's stock.

Insiders Place Their Bets

In other Stryker news, Director Allan C. Golston sold 2,458 shares of the firm's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the transaction, the director now owns 14,895 shares in the company, valued at $5,705,827.65. This trade represents a 14.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the sale, the director now owns 3,642,075 shares of the company's stock, valued at $1,428,567,498. This trade represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 5.50% of the company's stock.

Remove Ads

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Truist Financial boosted their price objective on shares of Stryker from $409.00 to $413.00 and gave the company a "hold" rating in a research report on Thursday, January 30th. Barclays boosted their price target on shares of Stryker from $418.00 to $443.00 and gave the company an "overweight" rating in a report on Monday, February 10th. Stifel Nicolaus increased their price objective on Stryker from $400.00 to $440.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. StockNews.com downgraded Stryker from a "buy" rating to a "hold" rating in a research note on Thursday, March 6th. Finally, Royal Bank of Canada raised their price target on Stryker from $425.00 to $435.00 and gave the stock an "outperform" rating in a research note on Wednesday, January 29th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, Stryker currently has a consensus rating of "Moderate Buy" and an average price target of $421.90.

Stryker Stock Performance

Shares of SYK stock traded down $9.34 during trading hours on Thursday, reaching $368.12. 3,306,021 shares of the company's stock were exchanged, compared to its average volume of 1,306,429. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19. The business has a fifty day moving average price of $382.64 and a 200-day moving average price of $374.41. The stock has a market capitalization of $140.51 billion, a P/E ratio of 47.44, a P/E/G ratio of 2.93 and a beta of 0.95. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, beating analysts' consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same period in the prior year, the firm posted $3.46 earnings per share. Analysts predict that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be issued a $0.84 dividend. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.36 annualized dividend and a yield of 0.91%. Stryker's dividend payout ratio (DPR) is 43.30%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.